Is Placental Growth Factor an angiogenic marker in type 2 diabetes mellitus?

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 2

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) known by vascular complications due to abnormal angiogenesis leading to micro and macro vascular complications. PlGF a close homolog of VEGF, shares receptors with VEGF, and stimulates angiogenesis. By up regulating PlGF and the signaling subtype of VEGFR-1, endothelial cells amplify their responsiveness to VEGF in many pathological conditions. Objectives: To compare and estimate serum PlGF and VEGF levels in patients with T2DM. Materials and Method: A case control study conducted with 30 type 2 diabetes mellitus and 30 age and sex matched healthy subjects as controls. All samples analyzed for FBS, HbA1C in an automated analyzer (Beckmann coulter AU480) and serum VEGF, PlGF was estimated by Biotin double antibody sandwich ELISA. Data analysis was done by using relevant statistical tests. Results: Mean PlGF and VEGF was significantly higher in cases as compared to control with p value of <0.0001 respectively. Serum PlGF showed positive correlation with VEGF, FBS and HbA1C with ‘r’ value of 0.867 (p=<0.0001), 0.555 (p=0.0014), 0.5951 (p=0.0005) respectively. Conclusion: Serum PlGF was significantly higher in cases than in controls and showed positive correlation with serum VEGF. PlGF stimulates angiogenesis, which is implicated in all the micro vascular complications of type 2 diabetes mellitus. Hence detecting PlGF early in the course of disease helps to prevent complications and in the management of complications of type 2 diabetes mellitus. Keywords: Type 2 Diabetes Mellitus, Angiogenesis, PlGF-Placental Growth Factor, VEGF-Vascular Endothelial Growth Factor, VEGFR 1 and 2- Vascular Endothelial Growth Factor Receptor 1 and 2

Authors and Affiliations

Uzma Talath, Prashanth Kumar B. G, Vishwanath H. L

Keywords

Related Articles

Levels of microalbuminuria in prediction of pre-eclampsia: A hospital based study

Introduction: Pre-eclampsia (PE) is defined as the new onset of hypertension and proteinuria during the second half of pregnancy. In the Indian scenario, it accounts for 44.44% of all cases of hypertensive disorders of p...

Reference interval of serum bilirubin panel in healthy individuals of attending tertiary care hospital - a cross sectional study

Introduction: Reference Intervals are the most common decision making tools for interpretation of various biochemical reports. Age, sex, ethnicity, diet, physical and socio-economic conditions, affect the physiology of p...

Effect of elevated iron stores on lipid profile in patients of type 2 diabetes mellitus

Introduction Diabetes Mellitus DM comprises a group of metabolic disorders presenting with hyperglycemia resulting from insulin deficiency or decreased glucose utilization and increased glucose production Ferritin is a g...

Effect of occupational lead exposure on the family members of lead based industrial workers

Introduction A comparative study of family members of persons working in lead based industries and nonlead based industries were undertaken to evaluate the effect of lead on family members of lead based industrial worker...

Uric acid in Type 2 Diabetes mellitus with nephropathy

Introduction: Uric acid is an important antioxidant that contributes for around 60% of free radical scavenging capacity of serum. Its role has been controversial in type 2 diabetes mellitus. Earlier studies have reported...

Download PDF file
  • EP ID EP296895
  • DOI 10.18231/2394-6377.2017.0040
  • Views 79
  • Downloads 0

How To Cite

Uzma Talath, Prashanth Kumar B. G, Vishwanath H. L (2017). Is Placental Growth Factor an angiogenic marker in type 2 diabetes mellitus?. International Journal of Clinical Biochemistry and Research, 4(2), 175-177. https://europub.co.uk./articles/-A-296895